Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Advanced Thyroid Cancer
NCT00625846Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of pazopanib in differentiated thyroid cancer (DTC), Medullary Thyroid Cancer (MTC), anaplastic thyroid cancer (ATC), sponsored by National Cancer Institute. Started Feb 2008; status: completed.
02
Drugs
pazopanib
03
Conditions
differentiated thyroid cancer (DTC)Medullary Thyroid Cancer (MTC)anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT00625846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625846.